These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 137762)

  • 21. Replacement of the canine inferior vena cava with a seeded graft.
    Shimizu M; Suzuki S; Takaya S; Satoh K
    Surg Today; 2001; 31(5):421-7. PubMed ID: 11381506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Grafting of a dacron blood vessel seeded with autogenous canine endothelial cells in the vein of dogs].
    Pu LQ
    Zhonghua Yi Xue Za Zhi; 1989 Sep; 69(9):519-21. PubMed ID: 2534285
    [No Abstract]   [Full Text] [Related]  

  • 23. Portal decompression by means of a gastroepiploic to inferior vena cava H graft.
    Adar R; Rubinstein Z
    Arch Surg; 1979 Nov; 114(11):1345-6. PubMed ID: 159029
    [No Abstract]   [Full Text] [Related]  

  • 24. Defibrinogenation by Arvin reduces air-drying-induced arteriosclerosis in rat carotid artery.
    van Pelt-Verkuil E; van de Ree P; Emeis JJ
    Thromb Haemost; 1989 Apr; 61(2):246-9. PubMed ID: 2749599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Capillary and venule proliferation in the healing process of Dacron venous grafts in rats.
    Zhang H; Williams GM
    Surgery; 1992 Apr; 111(4):409-15. PubMed ID: 1373008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental replacement of the inferior vena cava: factors affecting patency.
    Gloviczki P; Hollier LH; Dewanjee MK; Trastek VF; Hoffman EA; Kaye MP
    Surgery; 1984 Jun; 95(6):657-66. PubMed ID: 6729703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prosthetic replacement of the suprarenal inferior vena cava: experimental model].
    Di Giovanni V; Colli R; Cina G; De Cosmo G; Napolitano M; Ferrante A
    Chir Patol Sper; 1984 Apr; 32(2):47-60. PubMed ID: 6242708
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prosthesis replacement of the inferior vena cava].
    Ratto GB; Frascio M; Secco GB; Canepa G; Fardelli R
    Minerva Chir; 1990 Jan; 45(1-2):37-40. PubMed ID: 2336155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of experimental venous and arterial thrombosis and bleeding to ancrod-induced defibrinogenation.
    Schumacher WA; Heran CL; Steinbacher TE
    Thromb Res; 1996 Jan; 81(2):187-94. PubMed ID: 8822133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation following defibrination with ancrod.
    Slade CL; Andes WA; Mason AD
    Thromb Haemost; 1976 Nov; 36(2):424-9. PubMed ID: 1036842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant reconstruction of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal rhabdomyosarcoma.
    Anaya-Ayala JE; Cheema ZF; Davies MG; Lumsden AB; Reardon MJ
    Vasc Endovascular Surg; 2011 Nov; 45(8):769-72. PubMed ID: 21914678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The antiplatelet activity of ancrod on administration to rabbits.
    Chang MC; Huang TF
    J Lab Clin Med; 1995 Apr; 125(4):508-16. PubMed ID: 7706907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-thrombogenic effects of 2-hydroxyethylmethacrylate-styrene block copolymer and argatroban in synthetic small-caliber vascular grafts in a rabbit inferior vena cava model.
    Terada S; Suzuki K; Nozaki M; Okano T; Takemura N
    J Reconstr Microsurg; 1997 Jan; 13(1):9-16. PubMed ID: 9120844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
    Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
    Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutaraldehyde-tanned mandril-grown grafts as venous substitutes.
    Ratto GB; Romano P; Truini M; Frascio M; Rovida S; Badini A; Zaccheo D
    J Thorac Cardiovasc Surg; 1991 Sep; 102(3):440-7. PubMed ID: 1881182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patency in canine inferior vena cava grafting: effects of graft material, size, and endothelial seeding.
    Gerlock AJ; Phifer TJ
    J Vasc Surg; 1985 Sep; 2(5):765. PubMed ID: 4032618
    [No Abstract]   [Full Text] [Related]  

  • 38. Prosthetic replacement of the infrahepatic inferior vena cava for leiomyosarcoma.
    Illuminati G; Calio' FG; D'Urso A; Giacobbi D; Papaspyropoulos V; Ceccanei G
    Arch Surg; 2006 Sep; 141(9):919-24; discussion 924. PubMed ID: 16983035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Total cavopulmonary connection using a knitted dacron prosthesis impregnated with gelatin (GELSEAL) as an intracardiac conduit].
    Iwaya F; Tanji M; Ono T; Tsuda A; Hoshino S
    Nihon Kyobu Geka Gakkai Zasshi; 1996 May; 44(5):653-8. PubMed ID: 8964995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physiologic alteration of fibrinogen levels: influence upon patency of microvenous anastomoses.
    Cooley BC; Fowler JD; Gould JS
    Microsurgery; 1992; 13(6):299-303. PubMed ID: 1453930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.